Table 1:  Risk Factors for Venous Thromboembolism.

  General
  Age
  Trauma
  Surgery
  Leg immobilization or paralysis
  Central venous catheter (for intravenous administration) or
   transvenous pacemaker
  Confinement in hospital or nursing home
  Prior superficial venous thrombosis
  Varicose veins
  Acquired Risk Factors
 
Malignancy
  Myeloproliferative disorders, such as leukemia and polycythemia
   vera
  Heparin-induced thrombocytopenia (decrease in platelet
   count due to heparin therapy)
  Kidney defects
  Disseminated intravascular coagulation (overstimulation of blood
   clotting factors)
  Oral contraceptive use and estrogen therapy
  Lupus anticoagulant/anticardiolipin antibody (clotting disorder
   found in 10-30% of people with lupus erythematosus)
  Pregnancy and postpartum period (period after childbirth)
  Paroxysmal nocturnal hemoglobinuria (episodic loss of
   hemoglobin)
  Anticancer drug use
  Inflammatory bowel disease
  Thromboangiitis obliterans, also called Buerger's disease
   (inflammation and clotting in the lower extremities, mainly in
   young men).
  Behçet's syndrome (chronic inflammation of the blood vessels of
   the eyes and mucous membranes, mostly affecting young men)
  Familial Risk Factors
  Antithrombin III deficiency (clotting disorder)
  Protein C and protein S deficiency (clotting disorders)
  Activated protein C resistance (coagulation disorder)
  Dysfibrinogenemia (deficiency of fibrinogen, a clotting factor, in
   the blood)
  Hypoplasminogenemia (deficiency of plasminogen, a clotting
   factor, in the blood)
  Hyperhomocysteinemia (an excess of the amino acid
   homocysteine)
  -------------------------------------------------------------------------
  Modified from Gloviczki P, Yao, JST, eds. Handbook of Venous
  Disorders,
2nd ed. London: Arnold, 2001:226, Table 23.1

Venous thrombo-embolism is the overall term for a blood clot in a vein. These vein blood clots most commonly occur in the inner (deep) veins of the leg or pelvis (deep vein thrombosis). Because veins are carrying blood back to the heart from where it is pumped to the lungs, a deep vein thrombosis may dislodge from the leg veins, travel with the flowing blood back to the heart, and subsequently lodge in an artery to the lungs (as in pulmonary embolism). A pulmonary embolism may be fatal because blood cannot properly be resupplied with needed oxygen. Venous thromboembolism is a major health problem, with at least 201,000 new cases per year in the United States. One-fourth of affected patients die within 7 days of onset.

 

Whites and African-Americans have a higher incidence of venous thromboembolism; Hispanic-Americans are next and Asian-Americans are lowest. (Incidence is unknown among Native Americans.) Table 1 lists the major risk factors.

People who have had recent surgery have 22 times the risk for venous thromboembolism (Table 2).

Table 2. Percentage of Deep Venous Thrombosis (DVT) with No Prophylaxis, According to type of Surgery

  Type of Surgery   Prevalence of DVT
  General surgery   19%
  Abdominal/pelvic surgery for malignant disease   29%
  Total hip replacement   51%
  Total knee replacement   61%
  Hip fracture surgery   48%
  Neurosurgery   24%
  Surgery for multiple trauma   53%

Modified from Gloviczki P, Yao, JST, eds. Handbook of Venous Disorders, 2nd ed. London: Arnold, 2001:226, Table 23.2

The American Venous Forum mission: To promote venous and lymphatic health through innovative research, education and
technology.